|Articles|May 2, 2015
Jasmine Martin Discusses Oral Adherence
Author(s)Jasmine Martin
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
Advertisement
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
“If patients aren’t taking their drugs, then how do we know that the outcomes will be [the same as] what the clinical trial [outcomes] were?” Martin asks.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Basal Cell Carcinoma Basics, From Diagnosis to Treatment
2
Voranigo Continues to Benefit Patients With Grade 2 IDH-Mutated Glioma
3
Covering Every FDA Oncology Approval From October 2025
4
Areola Tattoos Help Patients Feel ‘As Normal as Possible’ After Breast Cancer
5
